| Mechanism of Fe(II) Oxidation and Core Formation in Ferritin | p. 1 |
| Chemico-Physical and Functional Differences Between H and L Chains of Human Ferritin | p. 13 |
| Iron Oxidation in Sheep, Horse and Recombinant Human Apoferritins | p. 23 |
| The Transferrin Receptor and the Release of Iron from Transferrin | p. 31 |
| The Roles of Secondary Binding Sites for Transferrin in the Liver and on Macrophages | p. 41 |
| Optimized Separation and Quantitation of Serum and Cerebrospinal Fluid Transferrin Subfractions Defined by Differences in Iron Saturation or Glycan Composition | p. 51 |
| Mechanism of Production of the Serum Transferrin Receptor | p. 61 |
| Iron Absorption and Cellular Uptake of Iron | p. 69 |
| Ferric Iron Reduction and Iron Uptake in Eucaryotes: Studies with the Yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe | p. 81 |
| Cellular Responses to Iron and Iron Compounds | p. 91 |
| The Structure and Function of Iron Regulatory Factor | p. 101 |
| Structure and Function of IREs, the Noncoding mRNA Sequences Regulating Synthesis of Ferritin, Transferrin Receptor and (Erythroid) 5-Aminolevulinate Synthase | p. 111 |
| Translational Control by Iron-Responsive Elements | p. 119 |
| The Role of Cytokines in the Regulation of Ferritin Expression | p. 127 |
| Stimulation of IRE-BP Activity of IREF by Tetrahydrobiopterin and Cytokine Dependent Induction of Nitric Oxide Synthase | p. 133 |
| Reciprocal Modulation of Aconitase Activity and RNA-binding Activity of Iron Regulatory Factor by Nitric Oxide | p. 141 |
| A New Look at Ferritin Metabolism | p. 149 |
| Bacterioferritin: A Hemoprotein Member of the Ferritin Family | p. 157 |
| Intracellular Iron | p. 165 |
| Distinct Features of Iron Metabolism in Erythroid Cells: Implications for Heme Synthesis Regulation | p. 173 |
| Cellular Ferritin Uptake: A Highly Regulated Pathway for Iron Assimilation in Human Erythroid Precursor Cells | p. 189 |
| Differential Effects of Iron and Iron Carrier on Hematopoietic Cell Differentiation and Human ADA Gene Transfer | p. 199 |
| A Hemin-Inducible Enhancer Lies 4.5 Kb Upstream of the Mouse Ferritin H Subunit Gene | p. 211 |
| Iron Deficiency: The Global Perspective | p. 219 |
| Iron Regulation in the Brain at the Cell and Molecular Level | p. 229 |
| Pathophysiology of Iron Toxicity | p. 239 |
| Morphologic Observations in Iron Overload: An Update | p. 255 |
| Identification of Thiolic Sarcolemmal Proteins as a Primary Target of Iron Toxicity in Cultured Heart Cells | p. 267 |
| Iron Overload and the Biliary Route | p. 277 |
| Changing Concepts of Haemochromatosis | p. 285 |
| Epidemiology, Clinical Spectrum and Prognosis of Hemochromatosis | p. 293 |
| The Morbidity of Hemochromatosis Among Clinically Unselected Homozygotes: Preliminary Report | p. 303 |
| Genetics of Haemochromatosis | p. 309 |
| Localization of Seven New Genes Around the HLA-A Locus | p. 319 |
| Searching for the Hemochromatosis Grail | p. 331 |
| Iron Chelator Design | p. 343 |
| Results from a Phase I Clinical Trial of HBED | p. 351 |
| Lessons from Preclinical and Clinical Studies with 1,2-Diethyl-3-Hydroxypyridin-4-One, CP94 and Related Compounds | p. 361 |
| Iron Chelation Therapy for Malaria | p. 371 |
| The Biochemical Basis for the Selective Antimalarial Action of Iron Chelators on Plasmodium Falciparum Parasitized Cells | p. 385 |
| Index | p. 399 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
